Norman Sharpless - Aug 4, 2022 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role
Director
Signature
/s/ James Stillman Hanson, attorney-in-fact
Stock symbol
GTHX
Transactions as of
Aug 4, 2022
Transactions value $
$0
Form type
4
Date filed
8/5/2022, 04:15 PM
Previous filing
Aug 2, 2022
Next filing
Jun 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHX Stock Options (Right to Buy) Award $0 +60K $0.00 60K Aug 4, 2022 Common Stock 60K $10.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in 36 equal monthly installments beginning August 31, 2022, subject to the Reporting Person's continued service through each applicable vesting date.